Exelon derivative settlement gets preliminary court approval; $40M insurance payout, governance reforms

EXELON CORP

Preliminary approval granted Nov 18, 2025 for consolidated derivative settlement related to ComEd bribery scheme.
Settlement includes $40M from insurers to Exelon; $30M will fund portion of $173M securities settlement.
Exelon to implement corporate governance reforms and reduce compensation of former CEO Christopher M. Crane.
Settlement resolves claims against current and former directors/officers for alleged fiduciary duty breaches.
Final approval hearing set for March 18, 2026 before Judge John Robert Blakey in N.D. Illinois.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.